Cargando…
Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?
To examine whether interleukin-6 in critical coronavirus disease 2019 is higher in arterial than in central venous blood, as a sign of predominantly local pulmonal rather than systemic interleukin-6 production. DESIGN: Prospective cohort pilot study with repeated weekly measurements of interleukin-6...
Autores principales: | Aarskog, Nikolai Ravn, Aass, Hans Christian, Holter, Jan Cato, Rostrup, Morten, Holten, Aleksander Rygh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480937/ https://www.ncbi.nlm.nih.gov/pubmed/34604785 http://dx.doi.org/10.1097/CCE.0000000000000542 |
Ejemplares similares
-
Missed Opportunity: The Unseen Driver for Low Coronavirus Disease 2019 Vaccination Rates in Underserved Patients
por: Campagnoli, Tania, et al.
Publicado: (2022) -
In Vitro–Administered Dexamethasone Suppresses T Cell Function With Reversal by Interleukin-7 in Coronavirus Disease 2019
por: Mazer, Monty B., et al.
Publicado: (2021) -
Secondary Bacterial Infections in Critical Ill Patients With Coronavirus Disease 2019
por: Fu, Yiqi, et al.
Publicado: (2020) -
Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020) -
Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy
por: Schwab, Kristin, et al.
Publicado: (2020)